Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Strides Pharma Science

02 4Aurobindo Pharma Limited

03 1Chartwell Pharmaceuticals llc

04 3Cipla

05 1Emcure Pharmaceuticals

06 1Epic Pharma. LLC.

07 1Farm Agon

08 2Hetero Drugs

09 1Lupin Ltd

10 1Macleods Pharmaceuticals Limited

11 1NORVIUM BIOSCIENCE

12 1Natco Pharma

13 1ORIFARM GROUP AS

14 1Pharmacare Premium

15 1Teva Pharmaceutical Industries

16 3Viatris

17 4ViiV Healthcare

18 1Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2015-05-13

Application Number : 79128

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 60MG

Packaging :

Approval Date :

Application Number : 22296

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2017-05-05

Application Number : 77558

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2012-05-15

Application Number : 202418

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2011-05-25

Application Number : 79081

Regulatory Info : DISCN

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2018-09-07

Application Number : 77411

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 60MG

Packaging :

Approval Date :

Application Number : 201151

Regulatory Info :

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET, FOR SUSPENSION; ORAL

Dosage Strength : 30MG; 60MG

Packaging :

Approval Date :

Application Number : 202814

Regulatory Info :

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 300MG

Packaging :

Approval Date :

Application Number : 78929

Regulatory Info :

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2018-04-10

Application Number : 206375

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2015-09-17

Application Number : 79124

Regulatory Info : RX

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2014-02-03

Application Number : 203259

Regulatory Info : RX

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2012-05-15

Application Number : 90246

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2018-08-29

Application Number : 90679

Regulatory Info : RX

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2014-08-28

Application Number : 204005

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2017-03-17

Application Number : 22018

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 60MG

Packaging :

Approval Date :

Application Number : 200748

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL SUSPENSION

Dosage Strength : 30MG; 60MG

Packaging :

Approval Date :

Application Number : 204914

Regulatory Info :

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : COMBIVIR

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 1997-09-26

Application Number : 20857

Regulatory Info : DISCN

Registration Country : USA

blank

20

NORVIUM BIOSCIENCE

Country
2024 ACI Convention
Not Confirmed
arrow

NORVIUM BIOSCIENCE

Country
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE

Brand Name : LAMIVUDINE AND ZIDOVUDINE

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;300MG

Packaging :

Approval Date : 2019-08-12

Application Number : 79079

Regulatory Info : DISCN

Registration Country : USA

blank